EGFR and adenocarcinoma: A 72-year-old Japanese male presented with an abnormal chest opacity that was determined to be adenocarcinoma of the left upper lobe at cT2aN1M1b Stage IV, without epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) translocation (Fig. 1a).